Latest news with #AdiaNutritionInc.
Yahoo
2 days ago
- Business
- Yahoo
Adia Nutrition Inc. Introduces Cherry Payment Plans at Adia Med Clinics, Enhancing Access to Innovative Therapies
Winter Park, Florida--(Newsfile Corp. - June 11, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), a leader in healthcare and nutritional supplements, is delighted to announce the introduction of Cherry Payment Plans at its Adia Med clinics, a growing clinical chain including the flagship Adia Med of Winter Park. This innovative financing option makes cutting-edge therapies more accessible by offering flexible, affordable payment solutions. To view an enhanced version of this graphic, please visit: The Cherry Payment Plans enable patients to spread treatment costs over manageable monthly installments, reducing financial barriers to accessing transformative therapies that can enhance their overall well-being. This initiative underscores Adia Nutrition's commitment to ensuring advanced treatments are within reach for those seeking to improve their personal vitality and appearance. "Launching Cherry Payment Plans is a pivotal step toward making our therapies more inclusive," said Larry Powalisz, Chief Executive Officer of Adia Nutrition. "We believe every patient deserves access to innovative care, and these flexible payment options empower more individuals to experience the potential of treatments at Adia Med." To view an enhanced version of this graphic, please visit: Adia Med of Winter Park, which opened in January 2025, is part of a rapidly expanding clinical network dedicated to personalized care. Patients can explore Cherry Payment Plans to enhance affordability. Those interested in treatment options or financing are encouraged to fill out the contact form at For questions, inquiries, or further information, please contact Larry Powalisz at ceo@ or 321-788-0850. A quick reminder: Adia Nutrition Inc. is presenting live today, June 11th, at 2:00 PM EST at the Life Sciences Virtual Investor Forum, hosted by About ADIA Nutrition Inc.:Adia Nutrition Inc. is a publicly traded company (OTCQB: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments. Website: Website: (X): @ADIA_Nutrition Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise. To view the source version of this press release, please visit
Yahoo
3 days ago
- Business
- Yahoo
Adia Nutrition Inc. to Present at the Life Sciences Virtual Investor Forum June 11th
Adia Nutrition Inc. invites individual and institutional investors, as well as advisors and analysts, to attend online at WINTER PARK, Fla., June 10, 2025 (GLOBE NEWSWIRE) -- Adia Nutrition Inc. (OTCQB: ADIA), based in Winter Park, Florida, focused on advancing regenerative medicine through stem cell therapies and nutritional solutions, today announced that Larry Powalisz, Chief Executive Officer, will present live at the Life Sciences Virtual Investor Forum, hosted by on June 11th, 2025. DATE: June 11th, 2025TIME: 2:00 PM ETLINK: REGISTER HEREAvailable for 1x1 meetings: June 12-13 This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event. It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates. Learn more about the event at Recent Company Highlights Opened Adia Med clinic in Winter Park, FL, in January 2025, offering Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for multiple sclerosis and autoimmune conditions. Expanded regenerative therapies with two premier stem cell and exosome products, Adia Vita, an FDA-registered 361 HCT/P umbilical cord stem cell product containing 100 million viable cells and 3 trillion exosomes per unit and AdiaLink, an FDA-registered 361 HCT/P exosome product containing 3.5 trillion exosomes per unit. Secured licensing agreements to meet global demand for Adia Med's regenerative therapies, announced June 9, 2025. Established subsidiaries Adia Labs LLC and Adia Med of Tinton Falls LLC to distribute and provide innovative treatments nationwide. For questions, inquiries or further information, please contact Larry Powalisz at ceo@ or 321-788-0850. About ADIA Nutrition Inc.:Adia Nutrition Inc. is a publicly traded company (OTCQB: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments. Website: Website: (X): @ADIA_Nutrition Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise. About Virtual Investor Conferences®Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors. Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings, and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors. Virtual Investor ConferencesJohn M. ViglottiSVP Corporate Services, Investor AccessOTC Markets Group(212) 220-2221johnv@
Yahoo
01-04-2025
- Business
- Yahoo
Judge Orders Cancellation of Over 25 Million Adia Nutrition Shares, Bolstering Shareholder Value
Winter Park, Florida--(Newsfile Corp. - April 1, 2025) - Adia Nutrition (OTC Pink: ADIA), a leader in innovative nutritional solutions, is pleased to announce a significant milestone for its shareholders following a recent court ruling. A judge has ordered the cancellation of over 25 million shares of Adia Nutrition stock, including more than 15 million restricted common shares and 10 million preferred shares. This landmark decision will reduce the company's outstanding shares by over 15 million, with Adia Nutrition having already contacted the transfer agent to initiate the share cancellation process, marking a pivotal step in enhancing shareholder value. Adia Nutrition Share Structure Before CancellationTo view an enhanced version of this graphic, please visit: The cancellation of these shares—comprising over 15 million restricted shares and 10 million preferred shares—reflects Adia Nutrition's commitment to optimizing its capital structure. This reduction in outstanding shares is expected to increase the value of remaining shares by concentrating ownership and improving earnings per share metrics, directly benefiting current investors. "This ruling is a win for our shareholders," said Larry Powalisz, CEO of Adia Nutrition. "By reducing the total number of outstanding shares, we're strengthening the company's financial foundation and enhancing the value of each share held by our loyal investors. This is just the beginning of our efforts to deliver long-term growth and stability." Adia Nutrition anticipates further strategic initiatives in the near future, signaling that more positive developments are on the horizon. The company remains dedicated to transparency and maximizing shareholder returns as it continues to innovate in the nutrition and wellness sector. For questions, inquiries or further information, please contact Larry Powalisz at ceo@ or 321-788-0850. About ADIA Nutrition Inc.:Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments. Website: Website: (X): @ADIA_Nutrition Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise. To view the source version of this press release, please visit Sign in to access your portfolio
Globe and Mail
01-04-2025
- Business
- Globe and Mail
Judge Orders Cancellation of Over 25 Million Adia Nutrition Shares, Bolstering Shareholder Value
Winter Park, Florida--(Newsfile Corp. - April 1, 2025) - Adia Nutrition (OTC Pink: ADIA), a leader in innovative nutritional solutions, is pleased to announce a significant milestone for its shareholders following a recent court ruling. A judge has ordered the cancellation of over 25 million shares of Adia Nutrition stock, including more than 15 million restricted common shares and 10 million preferred shares. This landmark decision will reduce the company's outstanding shares by over 15 million, with Adia Nutrition having already contacted the transfer agent to initiate the share cancellation process, marking a pivotal step in enhancing shareholder value. Adia Nutrition Share Structure Before Cancellation To view an enhanced version of this graphic, please visit: The cancellation of these shares—comprising over 15 million restricted shares and 10 million preferred shares—reflects Adia Nutrition's commitment to optimizing its capital structure. This reduction in outstanding shares is expected to increase the value of remaining shares by concentrating ownership and improving earnings per share metrics, directly benefiting current investors. "This ruling is a win for our shareholders," said Larry Powalisz, CEO of Adia Nutrition. "By reducing the total number of outstanding shares, we're strengthening the company's financial foundation and enhancing the value of each share held by our loyal investors. This is just the beginning of our efforts to deliver long-term growth and stability." Adia Nutrition anticipates further strategic initiatives in the near future, signaling that more positive developments are on the horizon. The company remains dedicated to transparency and maximizing shareholder returns as it continues to innovate in the nutrition and wellness sector. For questions, inquiries or further information, please contact Larry Powalisz at ceo@ or 321-788-0850. About ADIA Nutrition Inc.: Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division establishing Clinics that specialize in leading-edge stem cell therapies, most significantly Umbilical Cord Stem Cells (UCB-SC) and Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments. Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments. Website: Website: Website: Website: Website: Twitter (X): @ADIA_Nutrition Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
